189 related articles for article (PubMed ID: 26077551)
1. The association between adherence to cardiovascular medications and healthcare utilization.
Simon-Tuval T; Triki N; Chodick G; Greenberg D
Eur J Health Econ; 2016 Jun; 17(5):603-10. PubMed ID: 26077551
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory bowel disease: healthcare costs for patients who are adherent or non-adherent with infliximab therapy.
Wan GJ; Kozma CM; Slaton TL; Olson WH; Feagan BG
J Med Econ; 2014 Jun; 17(6):384-93. PubMed ID: 24673303
[TBL] [Abstract][Full Text] [Related]
3. The association between adherence to levothyroxine and economic and clinical outcomes in patients with hypothyroidism in the US.
Hepp Z; Lage MJ; Espaillat R; Gossain VV
J Med Econ; 2018 Sep; 21(9):912-919. PubMed ID: 29865926
[TBL] [Abstract][Full Text] [Related]
4. Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.
Ye X; Qian C; Liu J; St Peter WL
Pharmacotherapy; 2013 Oct; 33(10):1062-70. PubMed ID: 23798059
[TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotic adherence is associated with lower inpatient utilization and cost in bipolar I disorder.
Broder MS; Greene M; Chang E; Hartry A; Yan T; Yermilov I
J Med Econ; 2019 Jan; 22(1):63-70. PubMed ID: 30376745
[TBL] [Abstract][Full Text] [Related]
6. Association of Medication Adherence with Hospital Utilization and Costs Among Elderly with Diabetes Enrolled in a State Pharmaceutical Assistance Program.
Pednekar P; Heller DA; Peterson AM
J Manag Care Spec Pharm; 2020 Sep; 26(9):1099-1108. PubMed ID: 32857648
[TBL] [Abstract][Full Text] [Related]
7. Persistence, adherence, and all-cause healthcare costs in atazanavir- and darunavir-treated patients with human immunodeficiency virus in a real-world setting.
Farr AM; Johnston SS; Ritchings C; Brouillette M; Rosenblatt L
J Med Econ; 2016; 19(4):386-96. PubMed ID: 26640980
[TBL] [Abstract][Full Text] [Related]
8. Association of cinacalcet adherence and costs in patients on dialysis.
Lee A; Song X; Khan I; Belozeroff V; Goodman W; Fulcher N; Diakun D
J Med Econ; 2011; 14(6):798-804. PubMed ID: 21988567
[TBL] [Abstract][Full Text] [Related]
9. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.
Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L
Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808
[TBL] [Abstract][Full Text] [Related]
10. Impact of diagnosing and treating obstructive sleep apnea on healthcare utilization.
Walter RJ; Hagedorn SI; Lettieri CJ
Sleep Med; 2017 Oct; 38():73-77. PubMed ID: 29031760
[TBL] [Abstract][Full Text] [Related]
11. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.
Degli Esposti L; Saragoni S; Batacchi P; Benemei S; Geppetti P; Sturani A; Buda S; Degli Esposti E
Clin Ther; 2012 Jan; 34(1):190-9. PubMed ID: 22284998
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes.
Bansilal S; Castellano JM; Garrido E; Wei HG; Freeman A; Spettell C; Garcia-Alonso F; Lizano I; Arnold RJ; Rajda J; Steinberg G; Fuster V
J Am Coll Cardiol; 2016 Aug; 68(8):789-801. PubMed ID: 27539170
[TBL] [Abstract][Full Text] [Related]
13. Association Between Medication Adherence and the Outcomes of Heart Failure.
Hood SR; Giazzon AJ; Seamon G; Lane KA; Wang J; Eckert GJ; Tu W; Murray MD
Pharmacotherapy; 2018 May; 38(5):539-545. PubMed ID: 29600819
[TBL] [Abstract][Full Text] [Related]
14. Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study.
Chapman RH; Petrilla AA; Benner JS; Schwartz JS; Tang SS
Drugs Aging; 2008; 25(10):885-92. PubMed ID: 18808213
[TBL] [Abstract][Full Text] [Related]
15. Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia.
Vekeman F; Sasane M; Cheng WY; Ramanakumar AV; Fortier J; Qiu Y; Duh MS; Paley C; Adams-Graves P
J Med Econ; 2016; 19(3):292-303. PubMed ID: 26618853
[TBL] [Abstract][Full Text] [Related]
16. One-year adherence to oral antihyperglycemic medication and risk prediction of patient outcomes for adults with diabetes mellitus: An observational study.
Huber CA; Rapold R; Brüngger B; Reich O; Rosemann T
Medicine (Baltimore); 2016 Jun; 95(26):e3994. PubMed ID: 27368004
[TBL] [Abstract][Full Text] [Related]
17. Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris.
Tan X; Al-Dabagh A; Davis SA; Lin HC; Balkrishnan R; Chang J; Feldman SR
Am J Clin Dermatol; 2013 Jun; 14(3):243-51. PubMed ID: 23572294
[TBL] [Abstract][Full Text] [Related]
18. Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients.
Dhamane AD; Schwab P; Hopson S; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
Int J Chron Obstruct Pulmon Dis; 2017; 12():115-122. PubMed ID: 28053521
[TBL] [Abstract][Full Text] [Related]
19. Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence.
Balu S; Simko RJ; Quimbo RM; Cziraky MJ
Curr Med Res Opin; 2009 Nov; 25(11):2765-75. PubMed ID: 19785511
[TBL] [Abstract][Full Text] [Related]
20. The Price of a Neglected Zoonosis: Case-Control Study to Estimate Healthcare Utilization Costs of Human Brucellosis.
Vered O; Simon-Tuval T; Yagupsky P; Malul M; Cicurel A; Davidovitch N
PLoS One; 2015; 10(12):e0145086. PubMed ID: 26669738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
